Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Neoplasms by Histologic Type
×
Immunotherapy
×
Clear all
Filters
2
NCT05063565
2026-03-27
ROWAN
Boston Scientific Corporation
Phase 2
Active not recruiting
100 enrolled
NCT02197169
2018-07-16
TARGET-I
DNAtrix, Inc.
Phase 1
Completed
37 enrolled